Portable precision analyser sets new standards

Air monitoring

Portable precision analyser sets new standards

26 Feb, 2026

MRU GmbH proudly presents the MGAprime-H2, an innovative, portable automatic measuring system (P-AMS) specifically engineered for high-precision analysis of hydrogen (H2) and a broad range of other critical gas components in industrial and environmental applications.

Given the increasing importance of hydrogen as a clean energy carrier and the strict requirements for gas quality in processes such as biomethane injection or hydrogen production, precise measurement technology is indispensable. The MGAprime-H2 combines the performance of a stationary analyser with the flexibility for on-site deployment, offering outstanding stability and reliability.

The MGAprime-H2 is the answer to the complex measurement requirements of the energy transition. This device has been developed to offer plant operators and measurement service providers the highest level of precision and user-friendliness. Particularly noteworthy is the stable and drift-free NDIR technology, which ensures excellent data quality over long measurement periods, thus significantly contributing to process optimisation and safety."

The MRU MGAprime-H2 is the ideal choice for demanding applications, from emission monitoring in industrial plants to quality control in the hydrogen and biomethane value chain. It underscores MRU's commitment to technological leadership and sustainable energy solutions.

Latest News

IET 36.3 May

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Bacteria can defend against antibiotics using enzyme released by dying cells
Explore more Arrow
Pollution Solutions Online
Valmet to deliver automation system for CO₂ liquefaction plant advancing Finland's green transition
Explore more Arrow
Petro Online
Why more industries are moving beyond fixed oil change schedules
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow